Poster Downloads_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

top

Please input keywords

EN

Management team

Social Responsibility

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

Pharmacology service

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

Poster Downloads

Media Center

Poster Downloads

Brochure

SITC 2023: Development of a Preclinical CD98HC Mouse Model for Therapeutic Studies

SITC 2023: Generation and Validation of Humanized GARP/TGFB1 Mice for Testing Novel Anti-human GARP Antibodies

SITC 2023: Humanized CD200/CD200R Mice as a Tool for Evaluating Novel Therapeutics

SITC 2023: Humanized ICOS Mice as a Novel Tool for Predicting and Monitoring T-cell-mediated Immunotherapy Response

SITC 2023: Humanized NKP46 Mouse Models for Testing Novel NK Cell-based Immunotherapies

SITC 2023: Preclinical CD3-based Mouse Models for Evaluation of Bi-specific T-cell Engager Antibodies

SITC 2023: A Novel B2m-deficient Immunodeficient Model Expressing Human IL15 for Preclinical Evaluation of T Cell and NK Cell-based Therapies

ESMO2023: Phase I open-label, dose escalation and expansion study of YH003, an anti-CD40 agonist monoclonal antibody in combination with Toripalimab in patients (pts) with advanced solid tumours

IO Summit EU: YH013, a Common Light Chain Bispecific ADC Targeting EGFR and MET, Improves Preclinical Efficacy Over Its Parental Single-Targeting ADCs

1 2 3 4 5 … 12